Alexander A. Seelenberger's most recent trade in Vincerx Pharma Inc was a trade of 200,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2024 | 200,000 | 0 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2024 | 93,750 | 0 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 93,750 | 93,750 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2024 | 86,000 | 0 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 86,000 | 86,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2024 | 58,000 | 0 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 58,000 | 58,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 56,000 | 56,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2024 | 56,000 | 0 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2024 | 55,250 | 0 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 55,250 | 55,250 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Aug 2024 | 31,250 | 0 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 31,250 | 125,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 31,250 | 125,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 93,750 | 93,750 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | See Remarks | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 11 Aug 2023 | 10,500 | 30,280 | - | 0.9 | 9,968 | Common Stock |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 86,000 | 86,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 56,000 | 56,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2022 | 58,000 | 58,000 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2022 | 55,250 | 55,250 | - | - | Stock Option (right to buy) | |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 10.34 per share. | 22 Dec 2021 | 2,417 | 12,493 | - | 10.3 | 24,988 | Common Stock |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 12.61 per share. | 29 Jun 2021 | 7,950 | 7,950 | - | 12.6 | 100,260 | Common Stock |
| Vincerx Pharma Inc | Alexander A. Seelenberger | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2020 | 200,000 | 200,000 | - | - | Stock Option (right to buy) |